重组人生长激素（rhGH）对青春期患者有效。
Recombinant human growth hormone (rhGH) is effective in pubertal patients.
作者信息
Hokken-Koelega A C
机构信息
Department of Pediatrics, Sophia Children's Hospital, Erasmus University, Rotterdam, The Netherlands.
出版信息
Br J Clin Pract Suppl. 1996 Aug;85:12-3.
PMID:8995020
Abstract
Recombinant human growth hormone (rhGH) therapy in a dose of 28-30 i.u./m2/week results in a significant and sustained improvement of height in most pubertal patients with growth retardation secondary to chronic renal insufficiency (CRI), dialysis or after renal transplantation (RTx). Long-term data indicate that rhGH therapy leads to a significant improvement in the final height of growth-retarded pubertal patients after renal transplantation.
摘要
重组人生长激素（rhGH）以28 - 30国际单位/平方米/周的剂量进行治疗，可使大多数因慢性肾功能不全（CRI）、透析或肾移植（RTx）继发生长迟缓的青春期患者的身高得到显著且持续的改善。长期数据表明，rhGH治疗可使肾移植后生长迟缓的青春期患者的最终身高得到显著改善。
相似文献
1
Recombinant human growth hormone (rhGH) is effective in pubertal patients.重组人生长激素（rhGH）对青春期患者有效。
Br J Clin Pract Suppl. 1996 Aug;85:12-3.
2
3
4
The role of recombinant human growth hormone (rhGH) in pubertal patients.重组人生长激素（rhGH）在青春期患者中的作用。
Br J Clin Pract Suppl. 1996 Aug;85:14-7.
5
6
7
Is the response to rhGH in peritoneal dialysis patients less effective than in patients with chronic renal insufficiency.腹膜透析患者对重组人生长激素（rhGH）的反应是否比慢性肾功能不全患者更无效？
Br J Clin Pract Suppl. 1996 Aug;85:18-20.
8
Growth hormone treatment in children before and after renal transplantation.肾移植前后儿童的生长激素治疗
J Pediatr Endocrinol Metab. 1996 Jun;9 Suppl 3:359-64.
9
10
Use of recombinant human growth hormone (rhGH) in pubertal patients with renal disease.重组人生长激素（rhGH）在青春期肾病患者中的应用。
Br J Clin Pract Suppl. 1996 Aug;85:10-1.
Zotero 插件